• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FOXM1B的SUMO化修饰改变了其在MCF7人乳腺癌细胞中对MiR-200家族和JNK1调控的转录活性。

SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells.

作者信息

Wang Chiung-Min, Liu Runhua, Wang Lizhong, Nascimento Leticia, Brennan Victoria C, Yang Wei-Hsiung

机构信息

Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.

Department of Genetics and Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

出版信息

Int J Mol Sci. 2014 Jun 10;15(6):10233-51. doi: 10.3390/ijms150610233.

DOI:10.3390/ijms150610233
PMID:24918286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4100150/
Abstract

Transcription factor Forkhead Box Protein M1 (FOXM1) is a well-known master regulator in controlling cell-cycle pathways essential for DNA replication and mitosis, as well as cell proliferation. Among the three major isoforms of FOXM1, FOXM1B is highly associated with tumor growth and metastasis. The activities of FOXM1B are modulated by post-translational modifications (PTMs), such as phosphorylation, but whether it is modified by small ubiquitin-related modifier (SUMO) remains unknown. The aim of the current study was to determine whether FOXM1B is post-translationally modified by SUMO proteins and also to identify SUMOylation of FOXM1B on its target gene transcription activity. Here we report that FOXM1B is clearly defined as a SUMO target protein at the cellular levels. Moreover, a SUMOylation protease, SENP2, significantly decreased SUMOylation of FOXM1B. Notably, FOXM1B is selectively SUMOylated at lysine residue 463. While SUMOylation of FOXM1B is required for full repression of its target genes MiR-200b/c and p21, SUMOylation of FOXM1B is essential for full activation of JNK1 gene. Overall, we provide evidence that FOXM1B is post-translationally modified by SUMO and SUMOylation of FOXM1B plays a functional role in regulation of its target gene activities.

摘要

转录因子叉头框蛋白M1(FOXM1)是一种著名的主要调节因子,可控制DNA复制、有丝分裂以及细胞增殖所必需的细胞周期途径。在FOXM1的三种主要亚型中,FOXM1B与肿瘤生长和转移高度相关。FOXM1B的活性受翻译后修饰(PTM)调控,如磷酸化,但它是否被小泛素相关修饰物(SUMO)修饰尚不清楚。本研究的目的是确定FOXM1B是否被SUMO蛋白进行翻译后修饰,并确定FOXM1B在其靶基因转录活性上的SUMO化修饰情况。在此我们报告,在细胞水平上,FOXM1B被明确界定为一种SUMO靶蛋白。此外,一种SUMO化蛋白酶SENP2显著降低了FOXM1B的SUMO化修饰。值得注意的是,FOXM1B在赖氨酸残基463处被选择性SUMO化修饰。虽然FOXM1B的SUMO化修饰对于其靶基因MiR - 200b/c和p21的完全抑制是必需的,但FOXM1B的SUMO化修饰对于JNK1基因的完全激活至关重要。总体而言,我们提供了证据表明FOXM1B被SUMO进行翻译后修饰,且FOXM1B的SUMO化修饰在调控其靶基因活性中发挥功能性作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/734d5c1ccc87/ijms-15-10233-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/edc9fad229b8/ijms-15-10233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/c37fc5e3cb93/ijms-15-10233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/01eb2a549a72/ijms-15-10233-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/621691cd2a97/ijms-15-10233-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/99fe221ca2a1/ijms-15-10233-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/734d5c1ccc87/ijms-15-10233-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/edc9fad229b8/ijms-15-10233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/c37fc5e3cb93/ijms-15-10233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/01eb2a549a72/ijms-15-10233-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/621691cd2a97/ijms-15-10233-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/99fe221ca2a1/ijms-15-10233-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7d/4100150/734d5c1ccc87/ijms-15-10233-g006.jpg

相似文献

1
SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells.FOXM1B的SUMO化修饰改变了其在MCF7人乳腺癌细胞中对MiR-200家族和JNK1调控的转录活性。
Int J Mol Sci. 2014 Jun 10;15(6):10233-51. doi: 10.3390/ijms150610233.
2
Polo-like kinase 1-mediated phosphorylation of Forkhead box protein M1b antagonizes its SUMOylation and facilitates its mitotic function.Polo样激酶1介导的叉头框蛋白M1b磷酸化拮抗其SUMO化并促进其有丝分裂功能。
J Biol Chem. 2015 Feb 6;290(6):3708-19. doi: 10.1074/jbc.M114.634386. Epub 2014 Dec 22.
3
SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.SUMOylation 修饰 ATF3 改变了其对 TP53 基因调控的转录活性。
J Cell Biochem. 2013 Mar;114(3):589-98. doi: 10.1002/jcb.24396.
4
Oncogenic Human Papillomavirus 16E7 modulates SUMOylation of FoxM1b.致癌性人乳头瘤病毒16E7调节FoxM1b的SUMO化修饰。
Int J Biochem Cell Biol. 2015 Jan;58:28-36. doi: 10.1016/j.biocel.2014.11.002. Epub 2014 Nov 11.
5
Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.磷酸化和 sumoylation 缺陷的孕激素受体在乳腺癌进展过程中驱动增殖性基因特征。
Breast Cancer Res. 2012 Jun 14;14(3):R95. doi: 10.1186/bcr3211.
6
Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein.揭示细胞周期进程中 SUMOylation 动力学,揭示 FoxM1 作为关键有丝分裂 SUMO 靶标蛋白。
Mol Cell. 2014 Mar 20;53(6):1053-66. doi: 10.1016/j.molcel.2014.02.001. Epub 2014 Feb 27.
7
The Key Regulator for Language and Speech Development, FOXP2, is a Novel Substrate for SUMOylation.语言和言语发育的关键调节因子FOXP2是一种新型的SUMO化底物。
J Cell Biochem. 2016 Feb;117(2):426-38. doi: 10.1002/jcb.25288.
8
Doxorubicin down-regulates Kruppel-associated box domain-associated protein 1 sumoylation that relieves its transcription repression on p21WAF1/CIP1 in breast cancer MCF-7 cells.阿霉素下调Kruppel相关盒结构域相关蛋白1的类泛素化修饰,从而解除其对乳腺癌MCF-7细胞中p21WAF1/CIP1的转录抑制作用。
J Biol Chem. 2007 Jan 19;282(3):1595-606. doi: 10.1074/jbc.M606306200. Epub 2006 Nov 1.
9
Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.FOXM1 异构体表达失调驱动胰腺癌进展。
Cancer Res. 2013 Jul 1;73(13):3987-96. doi: 10.1158/0008-5472.CAN-12-3859. Epub 2013 Apr 18.
10
Sumoylated SnoN represses transcription in a promoter-specific manner.SUMO化修饰的SnoN以启动子特异性方式抑制转录。
J Biol Chem. 2006 Nov 3;281(44):33008-18. doi: 10.1074/jbc.M604380200. Epub 2006 Sep 11.

引用本文的文献

1
DeSUMOylating isopeptidase 1 participates in the faithful chromosome segregation and vincristine sensitivity.去SUMO化异肽酶1参与精确的染色体分离和长春新碱敏感性。
FASEB J. 2024 Dec 13;38(24):e70261. doi: 10.1096/fj.202401560RR.
2
Sumo-regulatory SENP2 controls the homeostatic squamous mitosis-differentiation checkpoint.Sumo 调节 SENP2 控制着稳态鳞状细胞有丝分裂-分化检查点。
Cell Death Dis. 2024 Aug 16;15(8):596. doi: 10.1038/s41419-024-06969-z.
3
Distinctive tumorigenic significance and innovative oncology targets of SUMOylation.

本文引用的文献

1
Sumoylation differentially regulates Sp1 to control cell differentiation.SUMOylation (类泛素化修饰)差异调控 Sp1 以控制细胞分化。
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5574-9. doi: 10.1073/pnas.1315034111. Epub 2014 Mar 27.
2
The conserved sumoylation consensus site in TRIM5α modulates its immune activation functions.TRIM5α 中的保守 SUMOylation 共识位点调节其免疫激活功能。
Virus Res. 2014 May 12;184:30-8. doi: 10.1016/j.virusres.2014.02.013. Epub 2014 Feb 25.
3
Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein.
SUMOylation 的独特肿瘤发生意义和创新肿瘤靶点。
Theranostics. 2024 May 19;14(8):3127-3149. doi: 10.7150/thno.97162. eCollection 2024.
4
Post-Translational Modification of ZEB Family Members in Cancer Progression.ZEB 家族成员在癌症进展中的翻译后修饰。
Int J Mol Sci. 2022 Dec 1;23(23):15127. doi: 10.3390/ijms232315127.
5
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis.肿瘤进展和转移中 EMT 的分子机制和治疗策略。
J Hematol Oncol. 2022 Sep 8;15(1):129. doi: 10.1186/s13045-022-01347-8.
6
Unconventional protein post-translational modifications: the helmsmen in breast cancer.非常规蛋白质翻译后修饰:乳腺癌中的舵手
Cell Biosci. 2022 Feb 25;12(1):22. doi: 10.1186/s13578-022-00756-z.
7
A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics.关于FoxM1在乳腺癌发生发展及治疗中的研究进展的叙述性综述。
Ann Transl Med. 2021 Nov;9(22):1704. doi: 10.21037/atm-21-5271.
8
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.微小RNA的miR-200家族:上皮-间质转化的精细调节因子及循环肿瘤生物标志物
Cancers (Basel). 2021 Nov 23;13(23):5874. doi: 10.3390/cancers13235874.
9
FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer.FOXM1:一种多功能癌蛋白及卵巢癌中新兴的治疗靶点
Cancers (Basel). 2021 Jun 19;13(12):3065. doi: 10.3390/cancers13123065.
10
SUMOylation Wrestles With the Occurrence and Development of Breast Cancer.小泛素样修饰与乳腺癌的发生发展相关
Front Oncol. 2021 Apr 21;11:659661. doi: 10.3389/fonc.2021.659661. eCollection 2021.
揭示细胞周期进程中 SUMOylation 动力学,揭示 FoxM1 作为关键有丝分裂 SUMO 靶标蛋白。
Mol Cell. 2014 Mar 20;53(6):1053-66. doi: 10.1016/j.molcel.2014.02.001. Epub 2014 Feb 27.
4
SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma.SUMOylation 改变与肝癌的多药耐药性有关。
Mol Med Rep. 2014 Mar;9(3):877-81. doi: 10.3892/mmr.2014.1882. Epub 2014 Jan 2.
5
PIASy-mediated sumoylation of SREBP1c regulates hepatic lipid metabolism upon fasting signaling.PIASy 介导的 SREBP1c 类泛素化修饰在禁食信号调控肝脏脂质代谢中的作用。
Mol Cell Biol. 2014 Mar;34(6):926-38. doi: 10.1128/MCB.01166-13. Epub 2013 Dec 30.
6
SUMOylation inhibits FOXM1 activity and delays mitotic transition.小泛素样修饰抑制叉头框蛋白M1活性并延迟有丝分裂转变。
Oncogene. 2014 Aug 21;33(34):4316-29. doi: 10.1038/onc.2013.546. Epub 2013 Dec 23.
7
Twist1 promotes gastric cancer cell proliferation through up-regulation of FoxM1.Twist1 通过上调 FoxM1 促进胃癌细胞增殖。
PLoS One. 2013 Oct 24;8(10):e77625. doi: 10.1371/journal.pone.0077625. eCollection 2013.
8
Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.FOXM1 异构体表达失调驱动胰腺癌进展。
Cancer Res. 2013 Jul 1;73(13):3987-96. doi: 10.1158/0008-5472.CAN-12-3859. Epub 2013 Apr 18.
9
FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis.FoxM1 通过促进肿瘤转移与非小细胞肺癌患者的不良预后相关。
PLoS One. 2013;8(3):e59412. doi: 10.1371/journal.pone.0059412. Epub 2013 Mar 25.
10
FOX(M1) news--it is cancer.福克斯新闻(M1)——这是癌症。
Mol Cancer Ther. 2013 Mar;12(3):245-54. doi: 10.1158/1535-7163.MCT-12-0712. Epub 2013 Feb 26.